AT1
[대역어] None
[용어속성] Term
[용어속성] Term
Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
Article
[키워드] absence
ACE2
Activation
analogue
Ang II
angiotensin
Angiotensin II
angiotensin receptor blocker
applied
ARB
ARBs
Arg
Artery
AT1
AT1R
binding
blocker
candesartan
carried
charge relay system
clinical study
COVID-19
COVID19
CRS
cumulative
cytokine
determine
disease
dose
Effect
energy
EXP3174
explain
hypertensive patient
implicated
infected with SARS-CoV-2
negative charge
protective effect
provided
recent
receptor
reducing
SARS-CoV-2
sartans
shown
therapy
Treatment
vasoconstriction
[DOI] 10.3390/biom11070979 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/biom11070979 PMC 바로가기 [Article Type] Article
SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19
Commentary
[키워드] ACE2
AT1
complex
COVID‐19
domain
human ACE2
Interaction
SARS‐CoV‐2
[DOI] 10.1111/cbdd.13898 PMC 바로가기 [Article Type] Commentary
[DOI] 10.1111/cbdd.13898 PMC 바로가기 [Article Type] Commentary
B 0 AT1 Amino Acid Transporter Complexed With SARS-CoV-2 Receptor ACE2 Forms a Heterodimer Functional Unit: In Situ Conformation Using Radiation Inactivation Analysis
Original Research
[키워드] 6M17
accompanied
ACE2
acid
Amino acid
amino acid transporter
angiotensin-converting enzyme-2
apical membrane
approach
AT1
B0AT1
coexpressed
complex
component
conformation
contribute
COVID-19
COVID-19 patients
dose
Enterocyte
expressed
expression
form
functional
Gut
human tissues
indicated
Interaction
intestine
linear
magnitude
membrane
membrane vesicle
membranes
mitigate
molecular docking
molecular weight
Neutral
neutral amino acid transport
obligatory
outbreak
Particles
persistence
physiological
purified
Radiation
radiation inactivation
reported
SARS-CoV-2
SARS-CoV-2 receptor
small intestine
sodium-dependent transport
Symptom
translational
Transport
transporter
treat
variant
virion
[DOI] 10.1093/function/zqab027 PMC 바로가기 [Article Type] Original Research
[DOI] 10.1093/function/zqab027 PMC 바로가기 [Article Type] Original Research
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms
Research paper
[키워드] α1-fAAB, Autoantibody targeting the alpha1-adrenoceptor
β2-fAAB, Autoantibody targeting the beta2-adrenoceptor
fAAB, Functional autoantibody
ACE2, Angiotensin-converting enzyme 2 receptors
activate
acute phase
agonists
analysed
AT1
AT1-fAAB, Autoantibody targeting the angiotensin II AT1 receptor
autoantibodies
autoantibody
Autoimmunity
Blood
cardiological
cardiovascular disease
cardiovascular disorder
caused
cells
Combination
Combined
COVID
COVID-19
COVID-19 patient
CRPS, Complex regional pain syndrome
detectable
ETA-fAAB, Autoantibody targeting the endothelin receptor
Extracellular
fatigue
Follow-up
G-protein
GPCR, G-protein coupled receptors
Health
independent
investigated
involved
long-COVID
M2-fAAB, Autoantibody targeting the muscarinic receptor
MAS-fAAB, Autoantibody targeting the MAS receptor
muscarinic
negative chronotropic
Neonatal
neurological
Neurological deficit
NOC-fAAB, Functionally active autoantibody against the nociceptin receptor
Occurrence
opposite
Other
Patient
patients
positive chronotropic
Post-covid-19 symptom
PoTS, Postural orthostatic tachycardia syndrome
RAS, Renin angiotensin system
receptor
receptors
recovered COVID-19 patient
reported
SARS-CoV-2
SARS, Severe acute respiratory syndrome
Symptom
Symptoms
syndrome
target receptor
the disease
[DOI] 10.1016/j.jtauto.2021.100100 PMC 바로가기 [Article Type] Research paper
[DOI] 10.1016/j.jtauto.2021.100100 PMC 바로가기 [Article Type] Research paper
Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19
칸데사르탄과 캡토프릴을 사용한 실험 데이터는 COVID-19에서 양날의 검 효과가 없음을 나타냅니다
Article
[키워드] ACE
ACE2
ACE2 expression
ACEi
ACEIs
ADAM17
angiotensin
angiotensin-converting enzyme 2
Anti-inflammatory
anti-inflammatory response
antihypertensives.
ARB
ARBs
AT1
AT2
blood pressure
candesartan
Captopril
Cell
cells
change
COVID-19
Culture
culture medium
cultures
Cytokines
decrease
drug
drugs
entry receptor
expression
full-length
healthy
hyperglycemia
increase
increase in
inhibited
lung
mechanisms
medium
metabolic syndrome
obesity
Patient
pneumocyte
Proinflammatory cytokine
proinflammatory cytokines
promote
RAS
RAS activity
RATs
receptor
receptor blocker
receptors
regulate
Renin
renin-angiotensin system
severe COVID-19
soluble ACE2
spike
Spike protein
syndrome
tissue
transmembrane
up-regulated
up-regulation
Viral
viral entry
viral spike protein
virus
[DOI] 10.1042/CS20201511 PMC 바로가기 [Article Type] Article
[DOI] 10.1042/CS20201511 PMC 바로가기 [Article Type] Article
SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells
SARS-CoV-2 스파이크 단백질은 상피 세포에서 지오텐신 II 수용체 신호 전달의 활성화에 의해 IL-6 트랜스 신호 전달을 촉진합니다
Research Article
[키워드] ACE2
ACE2 expression
Activation
acute respiratory distress
acute respiratory distress syndrome
ADAM
Aggressive
angiotensin
angiotensin converting enzyme
Angiotensin converting enzyme-2
Angiotensin II
AP-1
AT1
Author
c-Fos
candesartan
Candesartan cilexetil
cascade
Cell
cell interactions
cells
Characteristics
chemokines
classical
combating
coordination
Coronavirus infection
COVID-19
COVID-19 disease
COVID-19 disease severity
culture supernatant
cytokine
cytokine response
Cytokine storm
Cytokines
disease severity
down-regulation
ectopic expression
elevated
endothelial
Endothelial cell
epithelial
epithelial cell
epithelial cells
excessive inflammatory response
expressed
expressing
expression
Extracellular
generate
Host
human epithelial cell
human epithelial cells
human liver
hyper-inflammatory response
IL-6
IL-6R
indicated
induce
inducer
Infection
Inflammatory cytokine
inhibit
inhibited
Interaction
leads
Lung epithelial cells
Lung injury
Macrophage
macrophage activation
macrophages
MAPK
MCP-1
mechanism
mediators
Monocytes
monocytes/macrophage
monocytes/macrophages
Multi-organ damage
NF-κB
observation
pathology
pathway
patient sera
Phosphorylation
primary host
pro-inflammatory
promote
promoted
promotion
protease
protein expression
pulmonary epithelial cell
receptor
receptor antagonist
receptor protein
receptor signaling
referred to
Regulatory
residue
respiratory distress
Respiratory distress syndrome
SARS Coronavirus
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 spike
SARS-CoV-2 spike protein
secretion
Signaling
SOCS3
soluble IL-6R
Spike protein
STAT3
suggested
syndrome
therapeutic
therapeutic intervention
tissue damage
trans
trans-signaling
transcriptional
transmembrane
vascular endothelial cell
Viral
viral infection
viral spike protein
with COVID-19
[DOI] 10.1371/journal.ppat.1009128 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.ppat.1009128 PMC 바로가기 [Article Type] Research Article
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
Cell and Developmental Biology
[키워드] ACE
ACE2
activate
addition
Ang II
Ang-(1-7)
angiotensin
Angiotensin II
anti-inflammatory effect
AT1
AT1 receptor
binding
carried
cascade
cell entry
cellular receptor
cleavage
cleave
clinical trial
components
consequence
convert
Coronaviridae family
coronavirus
Course
COVID-19
database
domain
downregulation
effort
enzyme
facilitate
human cells
insight
Interaction
Intervention
intracellular signaling
involved
LILACS
Lung injury
mechanism
membrane fusion
membrane-bound
molecular interaction
pandemic
pathogen
Pathogenesis
pathogenesis of COVID-19
pathway
Pathways
Perspective
pro-inflammatory
promote
RAS
RBD
receptor
Renin
renin angiotensin system
Research
S2 domain
SARS-CoV-2
SARS-CoV-2 cell
SciELO
Scientific community
Signaling
spike glycoprotein
subunits
System
therapeutic target
TMPRSS2
transmembrane
treating COVID-19
Treatment
vasoconstriction
virus
[DOI] 10.3389/fcell.2020.559841 PMC 바로가기 [Article Type] Cell and Developmental Biology
[DOI] 10.3389/fcell.2020.559841 PMC 바로가기 [Article Type] Cell and Developmental Biology
Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention
Pharmacology
[키워드] ACE2
Alpha
alveolar cell
antagonists
Apoptosis
AT1
biological marker
blockade
blockers
capillary leakage
CDK9
Cell
cellular and molecular
chemotactic
clinical feature
clinical marker
contribute
COVID-19
COVID-19 immune response
CRP
cytokine release
Cytokine storm
Cytokines
cytoplasmic
Defense
Degradation
Dexamethasone
differentiation
Diffuse alveolar damage
downstream signaling pathway
doxycycline
element
elevated
elevated lactate dehydrogenase
entry of SARS-CoV-2
epithelial
estrogen receptor
expression
IL-17
IL-6
immune
immune response
Immunity
include
infiltration
Inflammatory
Inflammatory cytokine
inflammatory cytokine production
inflammatory signaling
inhibitor
initial
Injury
interferon response
Intervention
Ivermectin
Jak
kinase inhibitors
LDH
lung tissue
MAPK
mechanism
melatonin
membrane fusion
membrane-bound
molecular
monocyte
monocyte-derived macrophage
NETosis
NETs
neutrophil
Neutrophil extracellular trap
Neutrophil-to-lymphocyte ratio
NF-κB
NLR
p65
pathogenic
pathophysiology
pathway
Platelet
Pneumocytes
Point
Potential
pro-inflammatory
promote
Prophylaxis
provoke
receptor
reduce
Remdesivir
Research
respiratory epithelia
respiratory epithelial cells
SARS-CoV-2 coronavirus
selective
Signal transduction
skewed
subtype
T-cell
therapeutic interventions
therapeutic response
Therapeutics
thrombosis
TNF-α
type I interferons
type III
Vascular
Viral load
virus
[DOI] 10.3389/fphar.2020.01169 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.01169 PMC 바로가기 [Article Type] Pharmacology